Arberas-Jiménez Iñigo, García-Davis Sara, Rizo-Liendo Aitor, Sifaoui Ines, Morales Ezequiel Q, Piñero José E, Lorenzo-Morales Jacob, Díaz-Marrero Ana R, Fernández José J
Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna (ULL), Avenida Astrofísico Francisco Sánchez s/n, 38206 La Laguna, Tenerife, Spain; Departamento de Obstetricia y Ginecología, Pediatría, Medicina Preventiva y Salud Pública, Toxicología, Medicina Legal y Forense y Parasitología, Universidad de La Laguna (ULL), Tenerife, Spain; Red de Investigación Cooperativa en Enfermedades Tropicales (RICET), Spain.
Instituto Universitario de Bio-Orgánica Antonio González (IUBO AG), Universidad de La Laguna (ULL), Avenida Astrofísico Francisco Sánchez 2, 38206 La Laguna, Tenerife, Spain.
Biomed Pharmacother. 2022 May;149:112816. doi: 10.1016/j.biopha.2022.112816. Epub 2022 Mar 11.
Primary amoebic meningoencephalitis (PAM) is a central nervous system (CNS) disease caused by Naegleria fowleri that mainly affects children and young adults with fatal consequences in most of the cases. Treatment protocols are based on the combination of different antimicrobial agents, nonetheless there is the need to develop new anti-Naegleria compounds with low toxicity and full effects compared to the currently used drug combination. The marine environment is a well-established source of bioactive natural products. In this work, we have focused on the structure of Laurencia cyclolaurane-type sesquiterpenes as potential chemical model against Naegleria species. The effects of debromolaurinterol (1) to induce PCD/apoptosis-like events in Naegleria fowleri have been evaluated, revealing that this compound induced reduction of ATP production showing a decrease of 99.98% in treated parasite cells. A SAR analysis have been supported with molecular modeling and analysis of the in silico ADME/Tox properties of the Laurencia sesquiterpenes debromolaurinterol (1), laurinterol (2) and allolaurinterol (3), which reinforce cyclolaurane metabolites as plausible molecular models to develop PAM treatments.
原发性阿米巴脑膜脑炎(PAM)是一种由福氏耐格里阿米巴引起的中枢神经系统(CNS)疾病,主要影响儿童和年轻人,大多数情况下会导致致命后果。治疗方案基于不同抗菌药物的联合使用,尽管如此,仍需要开发毒性低且效果优于目前使用的药物组合的新型抗耐格里属化合物。海洋环境是生物活性天然产物的一个既定来源。在这项工作中,我们专注于环劳丹烷型倍半萜烯的结构,将其作为对抗耐格里属物种的潜在化学模型。已评估去溴劳因萜醇(1)在福氏耐格里阿米巴中诱导程序性细胞死亡/凋亡样事件的作用,结果表明该化合物可导致ATP生成减少,经处理的寄生虫细胞中ATP生成减少了99.98%。通过分子建模以及对劳伦西亚倍半萜烯去溴劳因萜醇(1)、劳因萜醇(2)和异劳因萜醇(3)的计算机辅助药物代谢动力学/毒性(ADME/Tox)特性分析,支持了构效关系(SAR)分析,这进一步证实环劳丹烷代谢物作为开发PAM治疗方法的合理分子模型。